Previous 10 | Next 10 |
"Thanks" to the SARS-CoV-2 coronavirus , all of us are living in a world that's suddenly gone topsy-turvy. For marijuana investors, last week saw a set of developments that at times seemed contradictory and counterintuitive. Two formerly high-flying cannabis companies, Canopy Growth (N...
Despite losing over half its value during the last three quarters of 2019, the legal marijuana industry hasn't exactly been a safe haven for investors during the COVID-19 pandemic. Several of the industries biggest names, in fact, have lost another third of their value since the start of 2020. ...
Over the last few weeks, CBD sales have soared. All as consumers buy product to combat rising levels of anxiety and stress. “CBD can specifically help manage stress levels and reduce anxiety, which can ultimately help us keep our immune systems strong,” says The Weed Blog . ...
COVID-19 continues to affect the cannabis space, but this past week was less about the virus and more about the activities of major players in the industry. One key company announced massive organizational changes, while several others shared their latest quarterly results ȁ...
Are These Penny Stocks On Robinhood A Buy Or Sell Right Now? While the Robinhood app has run into its share of troubles, it hasn’t stopped users from trading penny stocks. Even amid the Robinhood shut down, people are still using the app for quick, on the fly trading. Whether or not you...
The one Canadian cannabis player hitting it out of the park remains Aphria ( APHA ). Amazingly, the stock trades below $4 while posting FQ3 results that smashed analyst estimates. My bullish investment thesis was bolstered by the quarterly results despite the company pulling their guidan...
Aimed at aligning its operations to global cannabis supply and demand, Canopy Growth ( CGC -0.2% ) will implement the following initiatives : More news on: Canopy Growth Corporation, Aphria Inc., Tilray, Inc., Healthcare stocks news, Consumer stocks news, Stocks on the move, Read mo...
ACADIA Pharmaceuticals (NASDAQ: ACAD ) initiated with Buy rating and $60 (33% upside) price target at Jefferies. More news on: ACADIA Pharmaceuticals Inc., eHealth, Inc., Lumos Pharma, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
The cannabis industry has been a financial train wreck for the better part of a year, but Ontario-based Aphria (NYSE: APHA) has been consistently posting solid results of late. Its fiscal third-quarter earnings report -- released after the bell Tuesday -- was yet another home run. D...
Aphria Inc. (APHA) Q3 2020 Earnings Conference Call April 15, 2020, 09:00 AM ET Company Participants Katie Turner - ICR, Inc., IR Irwin Simon - Chairman and CEO Carl Merton - CFO Conference Call Participants Owen Bennett - Jefferies Chris Carey - Bank of America Andrew ...
News, Short Squeeze, Breakout and More Instantly...
Cannabis Industry Merger And Acquisitions In 2021 Many cannabis stocks have over the last several months been hit with a loss in trading momentum. This has led to many of the top cannabis stocks trading at lower prices. Yet so far in May pot stocks have been performing a bit more vo...